Skip to content

13F-HR filed by Avoro Capital Advisors LLC

Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 11:49:53 UTC, with 30 holding rows worth $9,690,900,114.

Accession
0001104659-26-127608
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 30 entries on the cover page, a total value of $9,690,900,114 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,690,900,114 with VALUE read as dollars as filed, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
UNITED THERAPEUTICS CORP DEL COM91307C102Stock2,755,555$1,493,207,699dollars as filed
ASCENDIS PHARMA A/SK08588103ORD SHS *A*5,050,000$1,150,541,500dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock2,888,888$960,728,593dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR1,000,000$958,910,000dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock1,833,333$923,926,499dollars as filed
KYMERA THERAPEUTICS INC501575104COM7,474,747$835,601,967dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM11,000,000$719,950,000dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock2,145,000$440,282,700dollars as filed
CYTOKINETICS INC23282W605COM NEW4,900,000$322,959,000dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS7,050,000$268,323,000dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY6,555,555$204,992,205dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock5,500,000$204,545,000dollars as filed
VERA THERAPEUTICS INC92337R101COMMON STOCK5,635,000$181,954,150dollars as filed
UNIQURE NVN90064101SHS6,727,777$162,543,092dollars as filed
CELCUITY INC15102K100COM1,500,000$119,280,000dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK23,888,888$116,338,885dollars as filed
OCULAR THERAPEUTIX INC67576A100COM12,380,300$94,956,901dollars as filed
DAMORA THERAPEUTICS INCG2646Y104COMM STK3,783,000$80,502,240dollars as filed
HEMAB THERAPEUTICS HLDGS INC423494103COM SHS1,892,372$58,360,752dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM2,500,000$51,475,000dollars as filed
SEPTERNA INC COM81734D104Stock1,300,000$50,869,000dollars as filed
ABIVAX SA-00370M103SPONSORED ADS488,000$48,321,760dollars as filed
SCRIBE THERAPEUTIC COM811033109COM2,598,973$47,834,098dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW1,410,000$41,933,400dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock1,770,000$41,559,600dollars as filed
Biohaven Pharmaceutical Holding Co. LtdG111OE107Common2,750,000$36,712,500dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK2,377,777$36,451,321dollars as filed
Braveheart Bio Inc10567X101COM1,255,000$25,351,000dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN2,849,402$10,713,752dollars as filed
LEXEO THERAPEUTICS INC52886X107COMMON STOCK525,000$1,774,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-26-127608this filing2026-11-16